Welcome to our dedicated page for Healthy Extracts news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on Healthy Extracts stock.
Healthy Extracts Inc. (OTCQB: HYEX) generates frequent news as a science-based nutraceutical and oral delivery technology company focused on heart, brain, gut and metabolic health. Company updates often highlight record quarterly net revenue, growth in subscription-based recurring revenue, and developments in its proprietary delivery platforms.
News coverage for HYEX commonly includes earnings and outlook announcements, such as record net revenue quarters and revised annual guidance, as well as details on adjusted EBITDA and cash flow trends. Releases also describe operational milestones, including maintaining a top-three category ranking on Amazon.com for certain products and expanding direct-to-consumer and retail channels.
Another major theme in Healthy Extracts news is corporate transactions and integration. The acquisition and merger of Gummy USA, a precision-dosed nutraceutical gummy manufacturer with a HACCP, GMP-certified and FDA-registered facility, has been covered in detail, including the associated change-of-control events disclosed in Form 8-K filings. Updates describe how this transaction adds in-house manufacturing, SureDose™ technology and new white-label and private-label customers.
Product and technology launches are also frequent topics. Recent releases have introduced STAT10 for statin users, 4Sleep for sleep support, Hydrate EZ™ and Mynus Sugar™ gel-packs using Gelteq technology, and the Whitney Johns Gut Health Straw™ based on functional fiber straw IP. These stories explain how new formulations and delivery systems expand Healthy Extracts’ addressable markets and support its growth roadmap.
Investors following HYEX news can expect coverage of financial performance, mergers and acquisitions, new product categories, white-label wins, and conference presentations at microcap and growth-focused investor events. Bookmark this page to monitor how recurring revenue, exclusive technologies and strategic partnerships shape the company’s ongoing narrative.
Healthy Extracts (OTCQB:HYEX) announced on April 16, 2026 that its subsidiary Gummy USA secured a U.S. manufacturing partnership with Imaraïs Beauty, launching with an initial order of nearly 4 million gummies across five SKUs for distribution to 4,800+ store locations with isle end-cap placements.
The collaboration leverages Imaraïs' retail footprint (Target, Ulta, Sprouts) and an influencer reach of 40 million followers, targeting rapid expansion in the $720 billion health & beauty market and scaling Gummy USA's manufacturing output for the year.
Healthy Extracts (OTCQB:HYEX) reported record 2025 results with net revenue up 45% to $4.5M driven largely by the merger with Gummy USA, product launches and expanded DTC and retail channels. Gross profit rose 27% to $2.4M (53.7% margin). GAAP net loss was $881,000; non-GAAP net income was $162,000 or $0.02 per share. Management projects 2026 net revenues could exceed $20M, reflecting anticipated ramp at Gummy USA's facility and expanded product commercialization.
Healthy Extracts (OTCQB:GELS) reported preliminary unaudited 2025 results showing net revenue up 45% to $4.5 million, driven by the Gummy USA merger, product launches, and channel expansion. Organic operations grew ~25% and subscription channels rose substantially, while management projects the new facility could reach a $20 million annual capacity in 2026.
Results are preliminary and subject to audit and revision before the company's Form 10-K filing.
Healthy Extracts (OTCQB:HYEX) reported record third-quarter and nine-month 2025 revenue driven by product launches and channel expansion. Q3 revenue rose 23% to $918,000 and 9M revenue rose 20% to $2.8M. Gross profit fell 26% in Q3 to $447,000 (48.7% margin) due to higher supply chain and raw material costs. Operating expenses increased 75% in Q3 to $907,000, partly from one-time merger and stock-for-services costs. Net loss was $395,000 (‑$0.06) in Q3 versus net income a year earlier. On October 1 the company completed a merger with Gummy USA, secured a 6 million gummy follow-on order, and said the new facility could reach $20M annual capacity in 2026. Cash was $189,000 at Sept 30. Management expects annualized net revenue >$11.5M by year-end.
Healthy Extracts (OTCQB:HYEX) was invited to present at the Trickle Research Microcap Conference on November 13, 2025 at Topgolf Centennial in Centennial, Colorado, with a live stream scheduled and a 3:06 p.m. Mountain time presentation.
Management will review the company platform, recent merger with Gummy USA completed in early October, and product growth: Q3 2025 net revenue expected +23% YoY, direct-to-consumer subscriptions +58%, Amazon Subscribe & Save orders +98%, and a 6 million gummy follow-on order contributing to a projected record Q4 and full year.
Healthy Extracts (OTCQB:HYEX) expects Q3 2025 net revenue of ~ $920,000, up 23% year-over-year and the highest third-quarter result on record.
Subscription growth drove results: Amazon "Subscribe & Save" customers rose 98% and direct-to-consumer subscriptions rose 58%. The company completed a merger with Gummy USA effective at the start of Q4 and announced a follow-on order for 6 million nutraceutical gummies expected to significantly boost Q4 revenue. New product launches in Q3 expanded categories to include sleep and gut health. Results are preliminary, unaudited and subject to revision ahead of the official Q3 report in November.
Healthy Extracts (OTCQB: HYEX) announced that its Gummy USA subsidiary received a 6 million gummy follow-on order for a proprietary women's formulation, scheduled to ship within four weeks. The gummies target hormonal-balance symptoms such as missed periods, acne, excess hair growth, infertility and weight gain and were developed with client medical advisors. Gummy USA cites selection over competitors for superior texture and flavor with challenging ingredients and says its HACCP, GMP-certified, FDA-registered facility is scaling to meet rising private-label demand. The company references a recent merger integrating R&D, manufacturing, distribution and sales.
Healthy Extracts (OTCQB:HYEX) announced significant developments following its merger with Gummy USA, as discussed by new CEO Don Swanson in a Money Channel interview. The merger integrates Gummy USA's proprietary SureDose™ technology with Healthy Extracts' product development and marketing platform.
The company reported strong financial performance with net revenues up 20% in H1 2025. Notable growth metrics include 88% increase in direct-to-consumer subscriptions and 107% growth in Amazon Subscribe & Save customers. The merger is expected to accelerate growth by over 50% in the coming year.
Healthy Extracts (OTCQB:HYEX), a nutraceutical technology company, will present at the ArcStone-Kingswood Growth Summit 2025 in Toronto on September 18, 2025. The company will showcase its strong financial performance, including a 20% increase in net revenues during H1 2025, driven by significant growth in subscription-based revenue with direct-to-consumer subscriptions up 88% and Amazon Subscribe & Save customers increasing 107% year-over-year.
The presentation will highlight their recent merger with Gummy USA, featuring the proprietary SureDose™ technology for precision-dosed nutraceutical gummies, and their new functional drinking straw technology launched through Whitney Johns Nutrition. The company maintains a top three category ranking on Amazon.com.
Healthy Extracts (OTCQB:HYEX) has launched two groundbreaking wellness products in North America: Hydrate EZ™ and Mynus Sugar™, featuring Gelteq's (NASDAQ:GELS) proprietary gel-based delivery system. Both products come in innovative 2-oz gel packs with no mixing required.
The company reported 20% revenue growth in H1 2025 and recently completed a transformative merger with Gummy USA, which is expected to accelerate growth by over 50%. The new products target significant market opportunities, with the hydration supplement market projected to reach $4.4 billion by 2034 and the carb blocker market expected to hit $2.5 billion by 2033.
The launch follows a distribution agreement with Gelteq announced in June, establishing HYEX as the operational backbone for Gelteq's products in North America. Products are available through Bergametna.com and Amazon, with promotional discounts of up to 20% for subscribers.